Initial Statement of Ownership

CytomX Therapeutics, Inc. Filed 2023-03-29 Acc 0001140361-23-014591

Documents 1

2023-07-20 3 Initial Statement of Ownership
2023-03-29 4 SVP, Chief Scientific Officer acquired 60,000 shares (grant or award)
2023-03-29 3 Initial Statement of Ownership
2023-03-27 S-8 Securities Offered to Employees in Benefit Plans
2023-03-27 8-K Results of operations
2023-03-27 10-K Annual Report
2022-03-28 3 Initial Statement of Ownership

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslF345X02/form3.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…